Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021
Agam K. Rao,Joann Schulte,Tai-Ho Chen,Christine M. Hughes,Whitni Davidson,Justin M. Neff,Mary Markarian,Kristin C. Delea,Suzanne Wada,Allison Liddell,Shane Alexander,Brittany Sunshine,Philip Huang,Heidi Threadgill Honza,Araceli Rey,Benjamin Monroe,Jeffrey Doty,Bryan Christensen,Lisa Delaney,Joel Massey,Michelle Waltenburg,Caroline A. Schrodt,David Kuhar,Panayampalli S. Satheshkumar,Ashley Kondas,Yu Li,Kimberly Wilkins,Kylie M. Sage,Yon Yu,Patricia Yu,Amanda Feldpausch,Jennifer McQuiston,Inger K. Damon,Andrea M. McCollum,Asma’u Aminu-Alhaji,Lauren Andersen,Matthew Arduino,Nicolette Bestul,Megan Bias,Mary J. Choi,Crystal Gigante,Madison Harkey,Kate Hendricks,Yonette Hercules,Farah Husain,Oladipupo Ipadeola,Robynne Jungerman,Theodora Khan,Grishma Kharod,Amber Kunkel,Amanda MacGurn,Audrey Matheny,Timothy McCleod,Faisal S. Minhaj,Jenna Mink,Clint Morgan,Yoshinori Nakazawa,Donovan Newton,Eddy Ortega,Lalita Priyamvada,Kay Radford,Joseph Rehfus,Muhammad Muhammad Saleh,Michael B. Townsend,Rita Traxler,Florence Whitehill,Xianfu Wu,Hui Zhao,Michelle Carruthers,Ivory Gomez,Samantha Groppell,Juan Jaramillo,Daniel Serinaldi,Jose Serrano,Joey Stringer,Jenna Gettings,Jessica Pavlick,José David Retana,Shelley Stonecipher,Rachael Straver,Inger-Marie Vilcins,Leisha D. Nolen,,
DOI: https://doi.org/10.15585/mmwr.mm7114a1
2022-04-08
Abstract:Monkeypox is a rare, sometimes life-threatening zoonotic infection that occurs in west and central Africa. It is caused by Monkeypox virus, an orthopoxvirus similar to Variola virus (the causative agent of smallpox) and Vaccinia virus (the live virus component of orthopoxvirus vaccines) and can spread to humans. After 39 years without detection of human disease in Nigeria, an outbreak involving 118 confirmed cases was identified during 2017-2018 (1); sporadic cases continue to occur. During September 2018-May 2021, six unrelated persons traveling from Nigeria received diagnoses of monkeypox in non-African countries: four in the United Kingdom and one each in Israel and Singapore. In July 2021, a man who traveled from Lagos, Nigeria, to Dallas, Texas, became the seventh traveler to a non-African country with diagnosed monkeypox. Among 194 monitored contacts, 144 (74%) were flight contacts. The patient received tecovirimat, an antiviral for treatment of orthopoxvirus infections, and his home required large-scale decontamination. Whole genome sequencing showed that the virus was consistent with a strain of Monkeypox virus known to circulate in Nigeria, but the specific source of the patient's infection was not identified. No epidemiologically linked cases were reported in Nigeria; no contact received postexposure prophylaxis (PEP) with the orthopoxvirus vaccine ACAM2000.